Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.
about
A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapiesChemotherapy-induced peripheral neurotoxicity: a critical analysisSystematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumoursThe validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology groupImproving symptom communication through personal digital assistants: the CHAT (Communicating Health Assisted by Technology) project.Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Can administrative data be used to measure chemotherapy side effects?Potential and challenges of patient-generated health data for high-quality cancer care.Case Example of Dose Optimization Using Data From Bortezomib Dose-Finding Clinical Trials.Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatmentIntensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts.Performance of different data sources in identifying adverse drug events in hospitalized patients.Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model.Evaluating and reporting dysphagia in trials of chemoirradiation for head-and-neck cancer.Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation.Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-lifeAspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/00Multidisciplinary health care professionals' perceptions of the use and utility of a symptom assessment system for oncology patientsCharacterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinomaConstruct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.Skin care management in cancer patients: an evaluation of quality of life and tolerability.Low interrater reliability in grading of rectal bleeding using National Cancer Institute Common Toxicity Criteria and Radiation Therapy Oncology Group Toxicity scales: a survey of radiation oncologists.Stakeholder perspectives on implementing the National Cancer Institute's patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors.Improving modern cancer care through information technologyBringing PROMIS to practice: brief and precise symptom screening in ambulatory cancer careA multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.Stereotactic Body Radiation Therapy for Prostate Cancer: What is the Appropriate Patient-Reported Outcome for Clinical Trial Design?Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survivalIntegrating mHealth in Oncology: Experience in the Province of TrentoPreliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4).A Clinical Prediction Model to Assess Risk for Chemotherapy-Related Hospitalization in Patients Initiating Palliative Chemotherapy.DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancerConcordance between patient reports of cancer-related symptoms and medical records documentationPatient-Reported Outcomes vs. Clinician Symptom Reporting During Chemoradiation for Rectal Cancer.Feasibility of using algorithm-based clinical decision support for symptom assessment and management in lung cancer.The use of capecitabine in daily practice: a study on adherence and patients' experiences
P2860
Q26827266-31F5DC9E-3F07-4DED-B4EA-43F7E9AE1839Q27010318-2D0431B3-D8E0-4C63-B912-72C0876ADFDFQ28071978-F944DC94-3FEE-4BE8-B475-C2F0F2610A14Q28680695-D6E59C1E-D276-4B77-BF96-EB3E68A377A6Q30562213-4F151683-2F20-4A44-BCC9-F8056CB0AE0EQ30565997-423693B6-C88E-4763-B91A-CE00F6A25004Q30877306-0A497CE8-7C03-4CF4-987E-C23F6A4A525CQ30926697-A53EC2AE-E012-47C5-94B5-9050DB82E3D1Q31050273-2D5D9A21-2AD8-4D36-B3C5-7A9B0653E7BDQ33647002-2DFFC8A0-1AFF-4B36-92CD-91BADD037E2EQ33809126-26D96CD3-4B7C-4A57-844A-909C4BA7944CQ33825878-A55C6DFC-749B-4D98-9FD8-7022DA4D21D2Q33843430-43752070-44CE-4590-8926-BC435698245AQ33854239-CAE3EF63-9AD1-4D14-B1DD-88B9740B538EQ33886464-80DB445E-6D3A-46EB-A94F-53BB31706C24Q33932158-1EBDCB29-8E4D-41A4-BB08-5711CEB7D364Q33946063-D5250B0B-8505-48E6-BAC8-085191A958EEQ34088877-C31B6D83-AD02-48A5-A8F3-45CC7D6030F2Q34199348-CAE8491A-C8DF-4876-B3AB-F06C74420B2FQ34459679-56BE1AB3-244A-467C-80F3-DEFF4EC75FF2Q34507381-F5B4D853-BBB4-435E-81DD-C26700FF635EQ34571228-30C88248-D250-46E1-9216-254F7F62EF43Q34700294-52CDB2E8-25C6-427E-90AF-657E6733C791Q34772278-24631B5A-BB54-4885-9887-8C6AE4B4B123Q35000584-4177FDAF-3B48-4908-B96F-363BD98A38B3Q35029533-3241359A-CECD-43B8-B6C6-F5400644D904Q35057370-A002E506-97AD-45CB-A99F-BF190B81C8AAQ35155016-24964985-E5E4-40F3-B438-9B6155BB7982Q35172772-2A44E5E0-50DE-479B-B220-D5E8E3663AC5Q35233601-34BC682F-9E85-4AA7-9BDD-2F72DF198AAAQ35626586-3A7ED893-17CB-466A-8AE6-4096EFAD8642Q35745777-896686F1-9818-4AD6-B641-A2AD1218C1A2Q35812261-5A074040-EDFB-4A93-AB76-8F6BEF82F125Q36002272-A77067A4-7645-4E7B-9867-F2EC830B4CBFQ36076727-D5C1E388-C0C3-44B4-A818-547EC1D07C81Q36156806-5790D396-519D-497B-B30A-45DF7FA2F7CCQ36205212-94D62074-2A4F-4401-9F1B-389A204DCB9BQ36206899-F5C599DE-429E-4A61-9B23-03FFC526AF79Q36207873-C3E18271-BB2B-415D-A0F9-8B06311A21DFQ36358178-8B312174-5A84-44C6-B37D-7F6DC1C3C8FE
P2860
Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Patient versus clinician sympt ...... f a questionnaire-based study.
@en
type
label
Patient versus clinician sympt ...... f a questionnaire-based study.
@en
prefLabel
Patient versus clinician sympt ...... f a questionnaire-based study.
@en
P2093
P1433
P1476
Patient versus clinician sympt ...... f a questionnaire-based study.
@en
P2093
Alexia Iasonos
Allison Barz
Ann Culkin
Deborah Schrag
Howard I Scher
Tiffani McDonough
P304
P356
10.1016/S1470-2045(06)70910-X
P577
2006-11-01T00:00:00Z